 |
|
|
 |
|
|
|
|
|
|
Early characterisation of Discovery bulks often helps identifying critical milestones to be included into the drug candidate preclinical development plan. Drugabilis regularly performs those measurements on minute bulk amounts.
Crystallinity and thermal profile assessment, hygroscopicity measurement, hot-stage microscopic observations, API physical form stability evaluation under stress conditions, hydrate and solvate identification, salt and polymorph screening, salt selection, relative stability of polymorphs are all studies performed at Drugabilis, thanks to our well-equipped characterisation platform.
 |
|
Specific characterisation issues related to formulation studies, physical compatibility between drug and excipients, API physical form change upon scale-up or synthetic route modification, proprietary drug delivery technologies and others should be raised to us. They will give Drugabilis the opportunity to design, every time possible, fast and adapted answers. |
|
|
|
|
|
|
 |
|
|
